Each year brings greater progress for human genomics, with the field steadily moving from promising research into tangible clinical and policy impact. In 2025, genetic insight continued to reshape what is possible in medicine.
Gene therapies delivered major breakthroughs, including treatments that halve cholesterol levels in patients with inherited cardiovascular risk, advances for people living with thalassemia and highly targeted approaches for leukaemia that reduce the need for traditional chemotherapy.
2025 also saw the first sustained slowing of Huntington’s disease, marking a long-awaited milestone for a condition historically considered untreatable. Together, these developments show how genomic understanding is translating into precise, less burdensome care.
Check out the rest of the feature here
